Bioxyne Limited (ASX:BXN)

Bioxyne Statistics

Total Valuation

Bioxyne has a market cap or net worth of AUD 123.20 million. The enterprise value is 120.96 million.

Market Cap	123.20M
Enterprise Value	120.96M

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioxyne has 2.24 billion shares outstanding. The number of shares has increased by 11.95% in one year.

Current Share Class	2.24B
Shares Outstanding	2.24B
Shares Change (YoY)	+11.95%
Shares Change (QoQ)	+4.16%
Owned by Insiders (%)	52.87%
Owned by Institutions (%)	n/a
Float	692.16M

Valuation Ratios

The trailing PE ratio is 13.86.

PE Ratio	13.86
Forward PE	n/a
PS Ratio	2.57
PB Ratio	6.11
P/TBV Ratio	6.21
P/FCF Ratio	434.80
P/OCF Ratio	60.84
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.38, with an EV/FCF ratio of 426.91.

EV / Earnings	13.49
EV / Sales	2.52
EV / EBITDA	11.38
EV / EBIT	12.21
EV / FCF	426.91

Financial Position

The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.27.

Current Ratio	2.79
Quick Ratio	1.32
Debt / Equity	0.27
Debt / EBITDA	0.50
Debt / FCF	18.94
Interest Coverage	237.82

Financial Efficiency

Return on equity (ROE) is 66.14% and return on invested capital (ROIC) is 36.27%.

Return on Equity (ROE)	66.14%
Return on Assets (ROA)	24.99%
Return on Invested Capital (ROIC)	36.27%
Return on Capital Employed (ROCE)	40.72%
Weighted Average Cost of Capital (WACC)	7.75%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.94
Inventory Turnover	3.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +150.00% in the last 52 weeks. The beta is 0.69, so Bioxyne's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+150.00%
50-Day Moving Average	0.05
200-Day Moving Average	0.04
Relative Strength Index (RSI)	55.98
Average Volume (20 Days)	4,347,405

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioxyne had revenue of AUD 47.95 million and earned 8.97 million in profits. Earnings per share was 0.00.

Revenue	47.95M
Gross Profit	19.69M
Operating Income	9.91M
Pretax Income	8.94M
Net Income	8.97M
EBITDA	10.20M
EBIT	9.91M
Earnings Per Share (EPS)	0.00

Balance Sheet

The company has 7.60 million in cash and 5.37 million in debt, with a net cash position of 2.24 million or 0.00 per share.

Cash & Cash Equivalents	7.60M
Total Debt	5.37M
Net Cash	2.24M
Net Cash Per Share	0.00
Equity (Book Value)	20.17M
Book Value Per Share	0.01
Working Capital	18.39M

Cash Flow

In the last 12 months, operating cash flow was 2.02 million and capital expenditures -1.74 million, giving a free cash flow of 283,338.

Operating Cash Flow	2.02M
Capital Expenditures	-1.74M
Free Cash Flow	283,338
FCF Per Share	0.00

Margins

Gross margin is 41.05%, with operating and profit margins of 20.66% and 18.70%.

Gross Margin	41.05%
Operating Margin	20.66%
Pretax Margin	18.65%
Profit Margin	18.70%
EBITDA Margin	21.26%
EBIT Margin	20.66%
FCF Margin	0.59%

Dividends & Yields

Bioxyne does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.95%
Shareholder Yield	-11.95%
Earnings Yield	7.28%
FCF Yield	0.23%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioxyne has an Altman Z-Score of 6.04 and a Piotroski F-Score of 5.

Altman Z-Score	6.04
Piotroski F-Score	5